Valuation: Celltrion, Inc.

Market Cap 41,187B 29.83B 25.98B 24.59B 22.34B 41.73B 2,856B 41.94B 293B 113B 1,452B 112B 110B 4,647B P/E 2026 *
27.3x
P/E 2027 * 23.3x
Enterprise Value 43.41B 31.44M 27.38M 25.91M 23.55M 43.99M 3.01B 44.2M 309M 119M 1.53B 118M 115M 4.9B EV / Sales 2026 *
7.86x
EV / Sales 2027 * 6.71x
Free-Float
60.59%
Yield 2026 *
0.42%
Yield 2027 * 0.43%
1 day+1.75%
1 week-0.28%
Current month-4.55%
1 month-10.30%
3 months+3.26%
6 months-8.10%
Current year+4.59%
1 week 174,600
Extreme 174600
182,400
1 month 174,600
Extreme 174600
202,000
Current year 158,500
Extreme 158500
239,047.62
1 year 158,500
Extreme 158500
239,047.62
3 years 114,250.83
Extreme 114250.828535
239,047.62
5 years 114,250.83
Extreme 114250.828535
239,247.57
10 years 64,487.59
Extreme 64487.593381
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 2015-03-19
Chief Executive Officer 42 2021-03-25
President 51 2026-02-12
Director TitleAgeSince
Chairman 68 -
Director/Board Member 61 2005-03-31
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
1/16/26 Sell 500 0.0002%
1/16/26 Sell 1,000 0.0004%
1/16/26 Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+1.75%-0.28%+12.42%+41.11% 29.83B
+0.88%+3.46%+1.07%+29.53% 46.18B
+0.23%+4.72%+44.32%+27.27% 44.35B
+0.52%-3.15%+349.53%+520.09% 42.21B
+1.55%+3.41%+6.40%+76.45% 40.19B
-0.20%+5.49%+23.57%+119.72% 17.17B
-3.49%-8.49% - - 15.7B
+0.73%+9.56%+23.78%+40.79% 15.32B
-2.45%+2.41%-3.16%-35.16% 13.09B
+3.02%+3.18%+84.44%+35.50% 13.45B
Average +0.64%+1.41%+60.26%+95.03% 27.75B
Weighted average by Cap. +0.76%+1.56%+73.57%+120.42%

Financials

2026 *2027 *
Net sales 5,521B 4B 3.48B 3.3B 2.99B 5.59B 383B 5.62B 39.26B 15.18B 195B 15.02B 14.69B 623B 6,344B 4.59B 4B 3.79B 3.44B 6.43B 440B 6.46B 45.11B 17.44B 224B 17.26B 16.87B 716B
Net income 1,536B 1.11B 969M 917M 833M 1.56B 106B 1.56B 10.92B 4.22B 54.12B 4.18B 4.08B 173B 1,785B 1.29B 1.13B 1.07B 968M 1.81B 124B 1.82B 12.69B 4.91B 62.91B 4.86B 4.75B 201B
Net Debt 2,224B 1.61B 1.4B 1.33B 1.21B 2.25B 154B 2.26B 15.81B 6.11B 78.38B 6.05B 5.91B 251B 1,371B 993M 864M 818M 743M 1.39B 95.05B 1.4B 9.75B 3.77B 48.31B 3.73B 3.65B 155B
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,956
Date Price Change Volume
26-09-17 ₩180,300.00 +1.75% 328,926
26-09-16 ₩177,200.00 -0.17% 259,646
26-09-15 ₩177,500.00 -0.73% 195,823
26-09-14 ₩178,800.00 +0.34% 396,196
26-09-11 ₩178,200.00 -1.44% 564,770
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
180,300.00KRW
Average target price
268,686.76KRW
Spread / Average Target
+49.02%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A068270 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!